The Patent Finder

Terms ending in 2040

Merck Sharp and Dohme LLC

Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,515,007In Silico Process for Selecting Protein Formulation Excipients
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,291,570Treatment of Metastatic Pancreatic Adenocarcinoma
In force
 · High confidence
Biolinerx Ltd. and Merck Sharp & Dohme Corp.In forceHigh confidence
US 11,377,4382-Amino-N-HETEROARYL-NICOTINAMIDES as NAV1.8 Inhibitors
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,427,616PCSK9 Antagonist Compounds
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,098,0295-Alkyl Pyrrolidine Orexin Receptor Agonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 12,331,018Pyrrolidine Orexin Receptor Agonists
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,872,558Well Plate Assembly with Pressure Release Mechanism
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,471,512Pharmaceutical Compositions of a Peptide
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,545,270Dossier Change Control Management System
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
US 11,312,7199-Substituted Amino Triazolo Quinazoline Derivatives as Adenosine Receptor Antagonists, Pharmaceutical Compositions and Their Use
In force
 · High confidence
Merck Sharp & Dohme LLCIn forceHigh confidence
20 more term ends in 2040 · Pro
10 of 30 patents shown. Soonest term end first, then patent number.
Pro members see all 30.
Upgrade to Pro
29 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited